Merck Diabetic Macular Edema Trial: Goal Met, Safety Flags
Merck diabetic macular edema trial: remigromig matched ranibizumab on vision in BRUNELLO, but PDR-related events were about 7x higher. What we know so far.
Merck diabetic macular edema trial: remigromig matched ranibizumab on vision in BRUNELLO, but PDR-related events were about 7x higher. What we know so far.